Kembali ke Daftar Obat
Panduan penyiapan dan pemberian terapi medikasi
Panduan penyiapan dan pemberian terapi medikasi
Midazolam
Risiko Phlebitis rendah
Kejadian Jarang/Berpotensi (>1/1000 kejadian)
Tetap waspada, gunakan dengan prosedur standar
Penyiapan
Sediaan
- 1 mg/mL
- 5mg/ml
Rekomendasi Pengenceran (Konsentrasi)
1mg/ml
Pelarut
- NaCl 0.9%
Pemberian
Rekomendasi Akses
IV
IM
IM
Rekomendasi Durasi Pemberian
Titrasi sesuai dosis dan berat badan pasien
Bolus 0,2mg/kgBB dalam 30 detik untuk induksi anestesi
Bolus 0,2mg/kgBB dalam 30 detik untuk induksi anestesi
Stabilitas Obat Setelah Rekonstruksi
72 jam pada suhu 25 derajat celcius
Keamanan
pH
2,9-3,7
pH risiko tinggi (<4 / >9)
Osmolaritas Sebelum Pengenceran
275-305
Osmolaritas rendah (<600)
Phlebitis
Ya
Jarang/Berpotensi (>1/1000 kejadian)
Tetap waspada, gunakan dengan prosedur standar
Tetap waspada, gunakan dengan prosedur standar
Inkompatibilitas
-
Amoxicillin sodium
-
Ketoconazole
-
Itraconazole
-
Voriconazole
-
Clarithromucin
-
Telithromycin
-
Boceprevir
-
Nefazodone
-
Aciclovir
-
Albumin
-
Alteplase
-
Aminophylline
-
Acetazolam Disodium
-
Dexamethasone sodium phosphate
-
Dimenhydrinate
-
Diazepam
-
Enoximone
-
Fluorouracil
-
Imipenem
-
Heparin sodium
-
Mezlocilin Sodium
-
Pantoprazole sodium
-
Phenobarbital Sodium
-
Phenytoin Sodium
-
Potassium Canrenoate
-
Ranitidine HCl
-
Sulbactam Sodium
-
Sodium bicarbonate
-
Theophylline
-
Trometamol
- Urokinase
Klasifikasi GHS
Acute Toxicity
Irritant
Health Hazard
Environment Hazard
Manifestasi GHS
H301 (77.9%): Toxic if swallowed [Danger Acute toxicity, oral]
H302 (22.1%): Harmful if swallowed [Warning Acute toxicity, oral]
H312 (28.6%): Harmful in contact with skin [Warning Acute toxicity, dermal]
H317 (27.3%): May cause an allergic skin reaction [Warning Sensitization, Skin]
H334 (27.3%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]
H361 (16.9%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
H362 (14.3%): May cause harm to breast-fed children [Reproductive toxicity, effects on or via lactation]
H411 (23.4%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard
H302 (22.1%): Harmful if swallowed [Warning Acute toxicity, oral]
H312 (28.6%): Harmful in contact with skin [Warning Acute toxicity, dermal]
H317 (27.3%): May cause an allergic skin reaction [Warning Sensitization, Skin]
H334 (27.3%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]
H361 (16.9%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
H362 (14.3%): May cause harm to breast-fed children [Reproductive toxicity, effects on or via lactation]
H411 (23.4%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard
Sumber
- https://www.medicines.org.uk/emc/product/6419/smpc#gref
- American Society of Health-System Pharmacists. 2021. ASHP® Injectable Drug Information: A Comprehensive Guide to Compatibility and Stability. 2021 Edition. eBook. American Society of Health-System Pharmacists. ISBN: 978-1-58528-690-4. doi.org/10.37573/9781585286850